{"title":"将耐药指数作为衡量抗菌药物管理规划实施效果的指标","authors":"K. Karnoukh, E. Shikh, N. Lazareva","doi":"10.32756/0869-5490-2022-3-67-73","DOIUrl":null,"url":null,"abstract":"To assess the changes in the drug resistance index (DRI), a composite measure that combines the level of resistance of individual pathogens with the extent of antimicrobial drugs consumption in a multidisciplinary hospital, after implementation of the antimicrobial stewardship program (AMSP) and during COVID-19 pandemic.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"612 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The drug resistance index as an indicator for the impact of antimicrobial stewardship program implementation\",\"authors\":\"K. Karnoukh, E. Shikh, N. Lazareva\",\"doi\":\"10.32756/0869-5490-2022-3-67-73\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To assess the changes in the drug resistance index (DRI), a composite measure that combines the level of resistance of individual pathogens with the extent of antimicrobial drugs consumption in a multidisciplinary hospital, after implementation of the antimicrobial stewardship program (AMSP) and during COVID-19 pandemic.\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"612 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2022-3-67-73\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2022-3-67-73","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The drug resistance index as an indicator for the impact of antimicrobial stewardship program implementation
To assess the changes in the drug resistance index (DRI), a composite measure that combines the level of resistance of individual pathogens with the extent of antimicrobial drugs consumption in a multidisciplinary hospital, after implementation of the antimicrobial stewardship program (AMSP) and during COVID-19 pandemic.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
